QA: Unicycive Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001766140_2025_Unicycive_Therapeutics_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001766140, Unicycive Therapeutics Inc

  xvar xval
0 AssetsCurrent 30,948,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 75,000
3 remainder_Assets 645,000
4 LiabilitiesCurrent 24,120,000
5 LiabilitiesNoncurrent 117,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,103,000
9 ResearchAndDevelopmentExpense 20,014,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -4,612,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 31,668,000
1 Liabilities 24,237,000
2 Expenses 32,117,000
3 Revenues 0
4 StockholdersEquity 7,431,000
5 NetIncome -36,729,000
6 ComprehensiveNetIncome -36,729,000
7 BaseVar 46,317,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.734
9 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time